Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
Theodore V Nguyen, Benjamin F Bitner, Ellen M Hong, Jonathan C Pang, Leo Li Tang Meller, Cecilia Nguyen, Edward C Kuan
The septal branch of the anterior ethmoid artery (sbAEA) is an underrecognized source of severe refractory epistaxis. Herein, we describe the presentation, predisposing factors, treatment strategies, and outcomes of a series of patients with this condition.
February 14, 2024: International Forum of Allergy & Rhinology
#22
LETTER
Aurelia Monk, Brian D Thorp, Brent A Senior, Adam J Kimple, Cristine Klatt-Cromwell, Charles S Ebert
No abstract text is available yet for this article.
February 11, 2024: International Forum of Allergy & Rhinology
#23
JOURNAL ARTICLE
Juan Carlos Hernaiz-Leonardo, Changwan Ryu, Athenea Pascual, Judy Fan, Maria Caray, Rogério Pezato, Julia Yang, Don Sin, Andrew Thamboo
BACKGROUND: Dysregulation of the airway microbiota is thought to contribute to airway inflammation in both chronic rhinosinusitis (CRS) and asthma. However, the relationship between the upper and lower airway microbiome remains unclear. METHODS: Sinus and lung brushes were collected from 29 CRS participants undergoing sinus surgery. DNA was extracted and submitted for 16s rRNA microbiome sequencing. Alpha and beta diversity metrics, taxonomic composition, and differences between individual taxa were compared for paired sinus and bronchial samples...
February 11, 2024: International Forum of Allergy & Rhinology
#24
JOURNAL ARTICLE
Achilles A Kanaris, David J Fei-Zhang, Lily B Fletcher, Stephanie S Smith, Urjeet A Patel, Jill N D'Souza, Daniel C Chelius, Anthony M Sheyn, Jeffrey C Rastatter
Social determinants of health interactively influence sinonasal cancer care and prognosis. Housing-transportation and socioeconomic status showed the largest associations with disparities. The social vulnerability index can reveal the social determinants of sinonasal cancers.
February 11, 2024: International Forum of Allergy & Rhinology
#25
REVIEW
Xinru Gong, Yijie Fu, Lei Zhou, Aiming Wei, Chongsheng Pan, Tianmin Zhu, Hui Li
BACKGROUND: Chronic rhinosinusitis (CRS) is a common and intractable disease in otorhinolaryngology, laying a heavy burden on healthcare systems. The worldwide researchers are making efforts to find solutions to this disease. Metabolomics has recently gained more and more traction, and might become a promising tool to unravel the complexity of CRS. This paper provides an overview of current studies on the metabolomics of various CRS subtypes. METHODS: We conducted a comprehensive literature search in PubMed, Web of Science, EMBASE, Google Scholar, and Cochrane Library, up to May 25, 2023...
February 11, 2024: International Forum of Allergy & Rhinology
#26
JOURNAL ARTICLE
Christine M Liu, Ethan J Han, Jakob L Fischer, Jess C Mace, Jose L Mattos, Karolin Markarian, Jeremiah A Alt, Todd E Bodner, Naweed I Chowdhury, Patricia H Eshaghian, Anne E Getz, Peter H Hwang, Ashoke Khanwalkar, Adam J Kimple, Jivianne T Lee, Douglas A Li, Meghan Norris, Jayakar V Nayak, Cameran Owens, Zara M Patel, Katie Poch, Rodney J Schlosser, Kristine A Smith, Timothy L Smith, Zachary M Soler, Jeffrey D Suh, Grant A Turner, Marilene B Wang, Jennifer L Taylor-Cousar, Milene T Saavedra, Daniel M Beswick
BACKGROUND: Chronic rhinosinusitis (CRS) is common in people with cystic fibrosis (PwCF). Rhinologic symptom prioritization and areas that influence CRS treatment choices, including pursuing endoscopic sinus surgery (ESS), remain understudied. METHODS: Adult PwCF + CRS were enrolled at eight centers into a prospective, observational study (2019-2023). Participants were administered the 22-SinoNasal Outcome Test (SNOT-22) survey and a modified SNOT-22 instrument examining symptom importance...
February 11, 2024: International Forum of Allergy & Rhinology
#27
JOURNAL ARTICLE
Christopher M Low, Allan R Wang, Michael Yong, Jayakar Nayak, Zara Patel, Peter H Hwang
Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.
January 31, 2024: International Forum of Allergy & Rhinology
#28
LETTER
Meghan Norris, Erin Lopez, Daniel Alicea Delgado, Brian Thorp, Christine Klatt-Cromwell, Brent Senior, Adam Kimple, Charles S Ebert
All intranasal corticosteroid spray formulations are safe to use in patients on pre-exposure prophylaxis. Beclomethasone nasal spray can be used safely with all HAART and PrEP regimens.
January 31, 2024: International Forum of Allergy & Rhinology
#29
JOURNAL ARTICLE
David J Cvancara, Heather A Wood, Mohamed Aboueisha, Thomas B Marshall, Tzu-Cheg Kao, James O Phillips, Ian M Humphreys, Waleed M Abuzeid, Ashton E Lehmann, Yoshiko Kojima, Aria Jafari
BACKGROUND: Patients with chronic rhinosinusitis (CRS) can experience cognitive dysfunction. The literature on this topic mostly reflects patient-reported measurements. Our goal was to assess cognitive function in patients with CRS using objective measures, including saccadic eye movements-a behavioral response reflecting cognitive and sensory information integration that is often compromised in conditions with impaired cognition. METHODS: Participants (N = 24 with CRS, N = 23 non-CRS healthy controls) enrolled from rhinology clinic underwent sinonasal evaluation, quality of life assessment (Sino-nasal Outcome Test 22 [SNOT-22]), and cognitive assessment with the Neuro-QOL Cognitive Function-Short Form, the Montreal Cognitive Assessment (MoCA), and recording of eye movements using video-oculography...
January 24, 2024: International Forum of Allergy & Rhinology
#30
JOURNAL ARTICLE
Soledad López-Enríquez, Cristina Porras-González, Ramón Moreno-Luna, Francisca Palomares, José Luis Muñoz-Bravo, Gonzalo Alba, Consuelo Santa-María, Juan Maza-Solano, Daniel Iván Martín-Jiménez, Antonio Pérez-Pérez, Rafael Moreno-Luna, Víctor Sánchez-Margalet, Serafín Sánchez-Gómez
T-cell activation in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) is enriched by late cytotoxic T cells. The proportion of early and intermediate activated cytotoxic T cells decreases in nasal polyps of patients with CRSwNP. Our results identify late activated cytotoxic T cells as potential biomarkers or therapeutic targets for patients with CRSwNP.
January 24, 2024: International Forum of Allergy & Rhinology
#31
JOURNAL ARTICLE
Alessandro Vinciguerra, Mario Turri-Zanoni, Marco Ferrari, Davide Mattavelli, Giorgio Sileo, Vittorio Rampinelli, Vincenzo Abbate, Benjamin Verillaud, Alberto Schreiber, Paolo Battaglia, Maurizio Bignami, Piero Nicolai, Paolo Castelnuovo, Philippe Herman
Nasoseptal flap with extended pedicle dissection is a low morbidity and high success rate flap. It is a flap that can be applied to reconstruct a wide range of ipsilateral skull base defects.
January 24, 2024: International Forum of Allergy & Rhinology
#32
JOURNAL ARTICLE
Thomas Radulesco, Alberto Maria Saibene, Justin Michel, Luigi Angelo Vaira, Jérôme R Lechien
Chatbot Generative Pre-trained Transformer (ChatGPT)-4 indicated more than twice additional examinations than practitioners in the management of clinical cases in rhinology. The consistency between ChatGPT-4 and practitioner in the indication of additional examinations may significantly vary from one examination to another. The ChatGPT-4 proposed a plausible and correct primary diagnosis in 62.5% cases, while pertinent and necessary additional examinations and therapeutic regimen were indicated in 7.5%-30.0% and 7...
January 24, 2024: International Forum of Allergy & Rhinology
#33
JOURNAL ARTICLE
Kolin E Rubel, Andrea Lopez, Rory J Lubner, Diane L Lee, Kristen Yancey, Rakesh K Chandra, Naweed I Chowdhury, Justin H Turner
INTRODUCTION: The modified five-item frailty index (mFI-5) is a validated risk stratification tool with the ability to predict adverse outcomes following surgery. In this study, we sought to use mFI-5 to assess the potential relationship between unhealthy aging and postoperative endoscopic sinus surgery (ESS) outcomes. METHODS: Patients who underwent sinus surgery at Vanderbilt between 2014 and 2018 were identified and assessed using the mFI-5, which is calculated based on the presence of five comorbidities: diabetes mellitus, hypertension requiring medication, chronic obstructive pulmonary disease, congestive heart failure, and non-independent functional status...
January 24, 2024: International Forum of Allergy & Rhinology
#34
JOURNAL ARTICLE
Masayoshi Takashima, J Pablo Stolovitzky, Randall A Ow, Stacey L Silvers, Chad M McDuffie, Marc Dean, Ahmad R Sedaghat, Bobby A Tajudeen
BACKGROUND: Minimally invasive temperature-controlled radiofrequency (TCRF) ablation of the posterior nasal nerve (PNN) demonstrated a significant larger treatment effect on the symptom burden of chronic rhinitis patients than a sham control (no energy delivery) at the 3-month primary endpoint of this trial. METHODS: Two-year posttreatment outcomes for patients treated in a prospective, multicenter, patient-blinded randomized controlled trial were determined by combining the index active treatment-arm and index control-arm crossover patients into a single group (after the primary endpoint) to evaluate the treatment effect durability and long-term effects on concomitant chronic rhinitis medication usage...
January 24, 2024: International Forum of Allergy & Rhinology
#35
JOURNAL ARTICLE
Eugenio De Corso, Silvia Baroni, Stefano Settimi, Maria Elisabetta Onori, Tiziana di Cesare, Rodolfo Francesco Mastrapasqua, Francesca Sarlo, Daniele Penazzi, Giuseppe D'Agostino, Leandro Maria D'Auria, Gabriele De Maio, Anna Rita Fetoni, Jacopo Galli
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) may have a heterogeneous response to medical/surgical treatments based on endotypes. Data correlating biomarkers and severity of the disease are lacking. We aimed to determine if IL-5 and calprotectin may be useful in defining severity of disease and identifying uncontrolled patients. METHODS: This was a case-control study including 81 patients with diffuse CRSwNP who underwent at least one previous surgery and treated with intranasal steroids...
January 24, 2024: International Forum of Allergy & Rhinology
#36
JOURNAL ARTICLE
Mu Xian, Jiaqi Yu, Zheng Li, Yingshi Piao, Chegnshuo Wang, Junfang Xian, Luo Zhang
BACKGROUND: To date, an effective means to preoperatively predict the malignant transformation of sinonasal inverted papilloma (SIP) remains lacking due to similarities in clinical appearance. This study aimed to retrospectively evaluate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters and microvessel structure in tumors with histologically confirmed SIP and inverted papilloma-associated squamous cell carcinoma (IP-SCC), as well as correlate DCE-MRI findings with angiogenesis biomarkers...
January 21, 2024: International Forum of Allergy & Rhinology
#37
REVIEW
Edward C Kuan, Eric W Wang, Nithin D Adappa, Daniel M Beswick, Nyall R London, Shirley Y Su, Marilene B Wang, Waleed M Abuzeid, Borislav Alexiev, Jeremiah A Alt, Paolo Antognoni, Michelle Alonso-Basanta, Pete S Batra, Mihir Bhayani, Diana Bell, Manuel Bernal-Sprekelsen, Christian S Betz, Jean-Yves Blay, Benjamin S Bleier, Juliana Bonilla-Velez, Claudio Callejas, Ricardo L Carrau, Roy R Casiano, Paolo Castelnuovo, Rakesh K Chandra, Vasileios Chatzinakis, Simon B Chen, Alexander G Chiu, Garret Choby, Naweed I Chowdhury, Martin J Citardi, Marc A Cohen, Roi Dagan, Gianluca Dalfino, Iacopo Dallan, Camila Soares Dassi, John de Almeida, Angelo P Dei Tos, John M DelGaudio, Charles S Ebert, Ivan H El-Sayed, Jean Anderson Eloy, James J Evans, Christina H Fang, Nyssa F Farrell, Marco Ferrari, Nancy Fischbein, Adam Folbe, Wytske J Fokkens, Meha G Fox, Valerie J Lund, Gary L Gallia, Paul A Gardner, Mathew Geltzeiler, Christos Georgalas, Anne E Getz, Satish Govindaraj, Stacey T Gray, Jessica W Grayson, Bradley A Gross, Jordon G Grube, Ruifeng Guo, Patrick K Ha, Ashleigh A Halderman, Ehab Y Hanna, Richard J Harvey, Stephen C Hernandez, Adam L Holtzman, Claire Hopkins, Zhigang Huang, Zhenxiao Huang, Ian M Humphreys, Peter H Hwang, Alfred M Iloreta, Masaru Ishii, Michael E Ivan, Aria Jafari, David W Kennedy, Mohemmed Khan, Adam J Kimple, Todd T Kingdom, Anna Knisely, Ying-Ju Kuo, Devyani Lal, Eric D Lamarre, Ming-Ying Lan, Hien Le, Matt Lechner, Nancy Y Lee, Jivianne K Lee, Victor H Lee, Corinna G Levine, Jin-Ching Lin, Derrick T Lin, Brian C Lobo, Tran Locke, Amber U Luong, Kelly R Magliocca, Svetomir N Markovic, Gesa Matnjani, Erin L McKean, Cem Meço, William M Mendenhall, Loren Michel, Shorook Na'ara, Piero Nicolai, Daniel W Nuss, Gurston G Nyquist, Gretchen M Oakley, Kazuhiro Omura, Richard R Orlandi, Nobuyoshi Otori, Peter Papagiannopoulos, Zara M Patel, David G Pfister, Jack Phan, Alkis J Psaltis, Mindy R Rabinowitz, Murugappan Ramanathan, Ryan Rimmer, Marc R Rosen, Olabisi Sanusi, Zoukaa B Sargi, Philippe Schafhausen, Rodney J Schlosser, Ahmad R Sedaghat, Brent A Senior, Raj Shrivastava, Raj Sindwani, Timothy L Smith, Kristine A Smith, Carl H Snyderman, C Arturo Solares, Satyan B Sreenath, Aldo Stamm, Katharina Stölzel, Baran Sumer, Pavol Surda, Bobby A Tajudeen, Lester D R Thompson, Brian D Thorp, Charles C L Tong, Raymond K Tsang, Justin H Turner, Mario Turri-Zanoni, Aaron M Udager, Thibaut van Zele, Kyle VanKoevering, Kevin C Welch, Sarah K Wise, Ian J Witterick, Tae-Bin Won, Stephanie N Wong, Bradford A Woodworth, Peter-John Wormald, William C Yao, Chien-Fu Yeh, Bing Zhou, James N Palmer
BACKGROUND: Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field. METHODS: In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence...
February 2024: International Forum of Allergy & Rhinology
#38
JOURNAL ARTICLE
Daniel I Martin-Jimenez, Ramon Moreno-Luna, Amparo Callejon-Leblic, Alfonso Del Cuvillo Bernal, Charles S Ebert, Juan M Maza-Solano, Jaime Gonzalez-Garcia, Serafin Sanchez-Gomez
Expanded types of functional endoscopic sinus surgery (FESS) significantly improve quality of life and reduce revision surgeries rates, supporting their early application for moderate-to-severe cases. Minimal clinically important difference may play as a crucial role in defining surgical treatment response (i.e., responder and super-responder conditions). Expanded FESS benefits patients with chronic rhinosinusitis with nasal polyps but more data are required to have a clearer understanding of its uses due to varied approaches and reported outcomes in the literature...
January 16, 2024: International Forum of Allergy & Rhinology
#39
JOURNAL ARTICLE
Bita R Naimi, Emily Garvey, Megha Chandna, Alexander Duffy, Stephanie R Hunter, Shreya Mandloi, Chase Kahn, Douglas Farquhar, Glen D'Souza, Mindy Rabinowitz, Marc Rosen, Elina Toskala, Johannes B Roedl, Adam Zoga, Gurston Nyquist, David Rosen
BACKGROUND: Post-COVID parosmia may be due to dysautonomia and sympathetic hyperresponsiveness, which can be attenuated by stellate ganglion block (SGB). This study evaluates SGB as a treatment for post-COVID olfactory dysfunction (OD). METHODS: Retrospective case series with prospective data of patients with post-COVID OD undergoing unilateral (UL) or bilateral (BL) SGB. Patients completed Brief Smell Identification Tests (BSIT) (12 points maximum) and post-procedure surveys including parosmia severity scores on a scale of 1 (absent) to 10 (severe)...
January 16, 2024: International Forum of Allergy & Rhinology
#40
JOURNAL ARTICLE
Eli O Meltzer, Joaquim Mullol, Jinnie Ko, Rebecca Saenz, John W Steinke, Lauren A Millette, Philippe Gevaert
BACKGROUND: Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have high incidence of sleep impairment. We evaluated the impact of omalizumab treatment on sleep characteristics and associated health status in patients with CRSwNP. METHODS: Prespecified exploratory analysis assessed outcomes from patients included in the POLYP 1 and POLYP 2 phase 3 clinical trials and the open-label extension. Sleep was assessed by the sleep domain of the Sino-Nasal Outcome Test-22 (SNOT-22; MCID > 4 in patients with CRS) and the Medical Outcomes Study Sleep Scale (MOS-Sleep)...
January 10, 2024: International Forum of Allergy & Rhinology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
